Pet Health
Cerenia Side Effects: What to Know and Where to Start
Cerenia can cause side effects in dogs and cats, including appetite loss, lethargy, drooling, vomiting, and diarrhea, although serious reactions are less common.
Key takeaways
Cerenia can cause side effects in dogs and cats, including appetite loss, lethargy, drooling, vomiting, and diarrhea, although serious reactions are less common.
- Cerenia is a prescription veterinary medication used to prevent or treat vomiting.
- Its active ingredient, maropitant citrate, works by blocking signals involved in the vomiting reflex.
- Most pets tolerate the medication, but reactions can vary depending on the animal, the formulation, and the reason for treatment.
- Pet owners should know which reactions to watch for, how long they might last, and when a change in behavior requires veterinary attention.
- The medication can control vomiting without treating the underlying illness, so continued symptoms still need investigation.
What Cerenia does in the body
Cerenia belongs to a group of medications called neurokinin-1 (NK1) receptor antagonists.
Its active ingredient, maropitant, blocks the action of substance P, a neurotransmitter involved in transmitting vomiting signals through the central nervous system.
By blocking substance P from attaching to NK1 receptors, Cerenia helps prevent the brain from triggering vomiting. It can be used to prevent acute vomiting in dogs, treat vomiting in cats through the injectable formulation, and prevent motion sickness-related vomiting in dogs through the tablet formulation.
The medication controls the vomiting response rather than curing the condition that causes it. A pet may still have an infection, gastrointestinal disease, toxin exposure, or another health problem even when vomiting stops.
The available formulations have different approved uses:
• Tablets: Approved for oral use in dogs to prevent acute vomiting and vomiting caused by motion sickness.
• Injection: Approved for preventing and treating acute vomiting in dogs and treating vomiting in cats.
Cerenia is not intended to work as a general pain reliever or sedative, and its primary purpose is controlling vomiting rather than treating nausea's underlying cause.
Pet owners researching cerenia should check which formulation their veterinarian prescribed because the approved uses, administration instructions, and adverse reactions differ between tablets and injections.
Short-term effects to watch for
Side effects can appear after a dose, although not every pet experiences them.
The reactions reported most often in dogs include decreased appetite, lethargy, excessive salivation, vomiting, and diarrhea.
Other reported reactions in dogs include:
• Drooling: Excessive saliva production or unusual lip licking.
• Low energy: Lethargy, depression, or reduced activity.
• Digestive problems: Vomiting, diarrhea, retching, or changes in stool.
• Trembling: Muscle tremors or shaking.
• Coordination problems: Ataxia, which can make a dog appear unsteady when walking.
• Appetite changes: Reduced interest in food or refusal to eat.
• Behavior changes: Anxiety, hyperactivity, or unusual panting.
Clinical trials provide some indication of how frequently reactions occurred. In a US motion sickness study involving dogs given Cerenia tablets, excessive salivation occurred in 12.5% of treated dogs, vomiting in 5.3%, muscle tremors in 1%, and sedation or depression in 1%.
These figures come from a particular study and use case, so they are not universal rates for every dog receiving Cerenia.
Cats receiving injectable Cerenia can also experience side effects. Reported reactions include lethargy, reduced appetite, excessive salivation, fever, and dehydration.
Injection discomfort deserves particular attention in cats. In a US clinical study, moderate behavioral responses to injection occurred in 22.6% of treated cats, while significant responses occurred in 11.3%. These responses included retreating, vocalizing, hissing, and scratching.
A pet with mild lethargy or reduced appetite may need monitoring, but persistent vomiting, worsening diarrhea, or a noticeable decline in energy warrants prompt veterinary assessment.
Long-term effects and repeated use
Cerenia has been studied in dogs receiving repeated doses, but the evidence for prolonged treatment is more limited than the evidence for short courses.
The approved treatment schedules depend on the reason for use and the formulation:
• Tablets for acute vomiting in younger dogs are labeled for up to five consecutive days.
• Tablets for motion sickness in dogs are labeled for up to two consecutive days.
• Injectable Cerenia for acute vomiting in dogs and cats is labeled for up to five consecutive days.
Dogs receiving longer treatment may experience changes in appetite and body weight. The prescribing information identifies dose-related decreases in both measures.
A clinical field trial examined daily tablet use over 28 consecutive days in a group of 32 dogs. Reported reactions included lethargy, vomiting, reduced appetite, corneal edema, and enlarged lymph nodes.
Longer safety studies also examined maropitant over 93 consecutive days. At the highest reported study dose of 20 mg/kg per day, dogs experienced occasional salivation and vomiting, weight loss, and lower serum albumin levels. Changes in certain cardiac electrical measurements were also observed.
Separate high-dose studies found that some changes in food consumption and body weight did not persist after treatment stopped.
These laboratory findings should not be confused with the expected effects of a routine prescribed course because the study conditions and doses differed from standard treatment.
For pets needing repeated treatment, appetite, weight, energy, and digestive health should be monitored throughout the treatment period.
Risks and medication interactions
Some pets need additional assessment before receiving Cerenia because their medical history can affect how the medication is handled or tolerated.
Liver disease
Maropitant is metabolized by enzymes in the liver, so the prescribing information recommends caution in dogs and cats with impaired liver function.
A pet with liver disease may need closer monitoring when receiving the medication.
Other medications
Cerenia binds strongly to plasma proteins, which creates a potential interaction concern with other highly protein-bound medications.
The prescribing information specifically identifies several medication groups that require attention:
• Nonsteroidal anti-inflammatory drugs (NSAIDs).
• Certain heart medications.
• Anticonvulsants used to control seizures.
• Behavioral medications.
The effects of combining Cerenia with these medications have not been fully evaluated in dogs and cats, so medication compatibility needs monitoring when additional treatment is required.
Young puppies
Cerenia requires particular care in very young puppies. The tablet prescribing information reports bone marrow hypocellularity, meaning reduced cellular activity in the bone marrow, at a higher frequency and severity in puppies younger than 11 weeks.
This finding was not observed in puppies 16 weeks of age and older in the cited safety observations.
Pregnancy and nursing
The safe use of Cerenia has not been evaluated in breeding animals or pregnant and lactating dogs and cats.
Gastrointestinal obstruction and toxin exposure
The safe use of Cerenia has not been evaluated in animals with gastrointestinal obstruction or those that have ingested toxins.
Because Cerenia controls vomiting rather than correcting the underlying condition, identifying the cause of vomiting remains an important part of treatment.
Do not give Cerenia to an animal with suspected obstruction or toxin exposure without immediate veterinary direction.
Dangerous reactions and overdose signs
Serious reactions are possible, although they are less commonly reported than digestive or appetite-related problems.
Post-approval reports for dogs receiving injectable Cerenia include allergic reactions, facial swelling, breathing difficulties, convulsions, coordination problems, and collapse.
Signs that require immediate attention include:
• Facial swelling: Swelling around the eyes, muzzle, or face can indicate a serious allergic reaction.
• Breathing difficulty: Labored breathing or sudden respiratory distress has been reported.
• Seizures: Convulsions or uncontrolled muscle movements are serious neurological signs.
• Loss of coordination: Severe unsteadiness or inability to walk normally can indicate a neurological reaction.
• Collapse: Loss of consciousness or inability to stand requires emergency assessment.
• Severe weakness: Marked weakness and lethargy have been observed in high-dose safety studies.
An overdose can produce more serious effects than those seen with routine treatment. In laboratory tolerance studies, dogs receiving repeated oral doses of 40 or 50 mg/kg daily for seven days developed weight loss, vomiting, soft stools, weakness, lethargy, and excessive salivation.
Other findings at these high doses included low potassium levels, reduced white blood cell counts characterized by neutropenia, changes in phosphorus levels, decreased heart rate, and prolonged corrected QT intervals.
These findings describe repeated high-dose exposure in controlled studies rather than a predictable outcome from every accidental extra dose.
If a pet swallows additional tablets or receives an incorrect injection amount, the amount taken, formulation, time of exposure, and animal's weight are important information for the veterinary team.
Facial swelling, breathing difficulty, seizures, collapse, or suspected overdose require emergency veterinary attention.
Reducing side effects and getting help
Careful administration and monitoring can help reduce preventable problems associated with Cerenia.
Follow the prescribed formulation and schedule.
Tablets and injections have different approved uses, and the injectable formulation should not be substituted for tablets when preventing motion sickness in dogs.
Use the recommended food instructions.
For motion sickness prevention, the tablet label recommends administration with a small amount of food at least two hours before travel. This helps reduce vomiting associated with giving the medication on an empty stomach. A full meal immediately before travel is not recommended.
Reduce injection discomfort.
The injectable product's prescribing information indicates that using refrigerated Cerenia may reduce the pain response associated with subcutaneous injection. Administration should remain under veterinary supervision.
Monitor changes after treatment.
Keep track of the following:
• Appetite and water consumption.
• Energy levels and normal activity.
• Vomiting or diarrhea.
• Drooling or unusual behavior.
• Walking and coordination.
• Swelling, pain, or irritation around an injection site.
Recording when the medication was given and when symptoms began can help the veterinary team assess a possible reaction.
Report suspected side effects.
Contact the prescribing clinic if a pet develops reduced appetite, unusual lethargy, diarrhea, drooling, or vomiting after treatment. Bring the medication packaging and a record of the amount and timing of each dose.
Before another dose, ask your veterinarian whether treatment should continue, change, or be reassessed.
If vomiting continues despite Cerenia, the underlying condition needs further evaluation rather than simply extending treatment.
Frequently asked questions
Does Cerenia make dogs sleepy?
Cerenia is described by its manufacturer as a non-sedating medication, meaning it is not intended to act as a sedative. However, lethargy and depression have been reported as adverse events, and drowsiness appeared in clinical trial findings.
How long does Cerenia last?
Cerenia is effective for approximately 24 hours, according to the manufacturer. The appropriate interval between doses depends on the animal, formulation, and reason for treatment.
Can humans take Cerenia?
No. Cerenia is a prescription veterinary medication and is not intended for human use. Accidental ingestion requires medical advice, while skin exposure can cause localized allergic reactions or skin sensitization after repeated exposure.
Can Cerenia cause vomiting even though it is an anti-vomiting medication?
Yes. Vomiting has been reported as an adverse reaction in clinical studies involving dogs receiving Cerenia tablets. Continued vomiting also requires investigation because the medication does not eliminate the underlying cause.
Editorial standards
Who wrote this guide
Written by VetWayfinder Editorial Team.
Every factual statement is tied to a cited source listed below. Report an error through the corrections page.
Sources
Each source supports at least one factual statement in this guide.
